Study summary · research use only
AOD-9604 Metabolic
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This brief note reports that the company Metabolic was developing AOD-9604 as a potential obesity treatment, and that by February 2002 phase IIa trials were underway. No study design, species, or outcomes are described.
Abstract
Metabolic is developing AOD-9604 for the potential treatment of obesity. By February 2002, phase IIa trials were underway.
pepmg summarizes the peer-reviewed literature and links to every source. It sells nothing and ships nothing. Where an FDA label, a peer-reviewed study or a clinical-trial registry entry (labeled trial registry, not peer-reviewed) has published a dose, pepmg reports it with the source named; it gives no personalized recommendations and no administration technique. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.